Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-01 Purchase |
2021-06-03 5:31 pm |
REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | VEDANTA PARTNERS LLC Vedanta Associates-R LP VEDANTA ASSOCIATES L.P. BETA OPERATORS FUND L.P. SAXENA PARAG 10% Owner |
1,330,000 | $3.75 | $4,987,500 | 2,699,876 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-10 Option Award |
2024-12-12 4:35 pm |
N/A 2034-12-09 |
REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | SAXENA PARAG Director 10% Owner |
8,200 | $0 | 8,200 (Direct) |
View |
| 2023-11-20 Other |
2023-11-22 6:28 pm |
N/A N/A |
REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | SAXENA PARAG VEDANTA PARTNERS LLC VEDANTA ASSOCIATES L.P. Director 10% Owner |
1,170,732 | $0 | 1,170,732 (Indirect) |
View |
| 2023-11-13 Option Award |
2023-11-14 4:18 pm |
N/A 2033-11-12 |
REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | SAXENA PARAG Director 10% Owner |
8,200 | $0 | 8,200 (Direct) |
View |
| 2022-11-10 Option Award |
2022-11-14 10:34 am |
N/A 2032-11-09 |
REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | SAXENA PARAG Director 10% Owner |
3,900 | $0 | 3,900 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 4:49 pm |
N/A 2031-12-07 |
REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | SAXENA PARAG Director 10% Owner |
5,300 | $0 | 5,300 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-16 6:04 pm |
N/A 2031-06-14 |
REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | SAXENA PARAG Director 10% Owner |
4,000 | $0 | 4,000 (Direct) |
View |
| 2020-12-15 Other |
2020-12-28 8:02 pm |
2020-12-14 2025-12-14 |
REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Tenzing LLC SAXENA PARAG Nayar Rahul Director 10% Owner |
540,500 | $0 | 0 (Direct) |
View |
| 2020-12-14 Other |
2020-12-28 8:00 pm |
2020-12-14 2025-12-14 |
REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Tenzing LLC SAXENA PARAG Nayar Rahul Director 10% Owner |
343,000 | $0 | 3,005,250 (Direct) |
View |
| 2020-12-14 Option Award |
2020-12-28 8:00 pm |
2020-12-14 2025-12-14 |
REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Tenzing LLC SAXENA PARAG Nayar Rahul Director 10% Owner |
197,500 | $0 | 3,005,250 (Direct) |
View |
| 2020-11-24 Other |
2020-11-27 4:06 pm |
N/A N/A |
Eucrates Biomedical Acquisition Corp. | EUCR | SAXENA PARAG Chief Executive Officer 10% Owner |
255,094 | $0 | 2,875,000 (Indirect) |
View |
Ownership |
2020-10-23 1:24 pm |
N/A N/A |
Eucrates Biomedical Acquisition Corp. | EUCR | SAXENA PARAG Chief Executive Officer 10% Owner |
0 | $0 | 2,875,000 (Indirect) |
View |